检验医学与临床
檢驗醫學與臨床
검험의학여림상
JOURNAL OF LABORATORY MEDICINE AND CLINICAL SCIENCES
2015年
4期
444-446
,共3页
邵宜波%李旭%谢琴秀%胡立芬%顾有为
邵宜波%李旭%謝琴秀%鬍立芬%顧有為
소의파%리욱%사금수%호립분%고유위
质粒介导喹诺酮类耐药基因%氟喹诺酮耐药%qnrB24%功能分析
質粒介導喹諾酮類耐藥基因%氟喹諾酮耐藥%qnrB24%功能分析
질립개도규낙동류내약기인%불규낙동내약%qnrB24%공능분석
plasmid mediated quinolone resistance gene%quinolonne drug%qnrB24
目的:对新的质粒介导喹诺酮耐药基因(qnrB24)进行相关研究和分析。方法对新发现的qnrB24基因阳性菌株进行转移接合实验,了解qnrB24对喹诺酮类药物的耐药性,碱裂解法提取接合子质粒,Southern blot明确质粒大小。采用热不对称交错聚合酶链反应(PCR)技术研究基因5′端以及3′端未知侧翼碱基序列。结果这个突变基因命名为qnrB24(Genbank登录号HM192542)。药敏试验结果显示携带qnrB24基因接合子对环丙沙星的最小抑菌浓度(M IC )值为0.125μg/m L ,左氧氟沙星M IC值为0.190μg/m L。接合子对常见氟喹诺酮类抗菌药物的敏感性较大肠杆菌J53受体菌下降约8~11倍,接合子耐药水平低于临床分离菌株。Southern杂交显示该基因位于约60.0 Kb质粒上。热不对称交错PCR结果显示,qnrB24基因5′端为假定的转座酶。结论 qnrB24通过质粒介导引起细菌对喹诺酮类药物的耐药性上升,容易发展成高水平耐药,因此需要监测其在细菌中的流行性。
目的:對新的質粒介導喹諾酮耐藥基因(qnrB24)進行相關研究和分析。方法對新髮現的qnrB24基因暘性菌株進行轉移接閤實驗,瞭解qnrB24對喹諾酮類藥物的耐藥性,堿裂解法提取接閤子質粒,Southern blot明確質粒大小。採用熱不對稱交錯聚閤酶鏈反應(PCR)技術研究基因5′耑以及3′耑未知側翼堿基序列。結果這箇突變基因命名為qnrB24(Genbank登錄號HM192542)。藥敏試驗結果顯示攜帶qnrB24基因接閤子對環丙沙星的最小抑菌濃度(M IC )值為0.125μg/m L ,左氧氟沙星M IC值為0.190μg/m L。接閤子對常見氟喹諾酮類抗菌藥物的敏感性較大腸桿菌J53受體菌下降約8~11倍,接閤子耐藥水平低于臨床分離菌株。Southern雜交顯示該基因位于約60.0 Kb質粒上。熱不對稱交錯PCR結果顯示,qnrB24基因5′耑為假定的轉座酶。結論 qnrB24通過質粒介導引起細菌對喹諾酮類藥物的耐藥性上升,容易髮展成高水平耐藥,因此需要鑑測其在細菌中的流行性。
목적:대신적질립개도규낙동내약기인(qnrB24)진행상관연구화분석。방법대신발현적qnrB24기인양성균주진행전이접합실험,료해qnrB24대규낙동류약물적내약성,감렬해법제취접합자질립,Southern blot명학질립대소。채용열불대칭교착취합매련반응(PCR)기술연구기인5′단이급3′단미지측익감기서렬。결과저개돌변기인명명위qnrB24(Genbank등록호HM192542)。약민시험결과현시휴대qnrB24기인접합자대배병사성적최소억균농도(M IC )치위0.125μg/m L ,좌양불사성M IC치위0.190μg/m L。접합자대상견불규낙동류항균약물적민감성교대장간균J53수체균하강약8~11배,접합자내약수평저우림상분리균주。Southern잡교현시해기인위우약60.0 Kb질립상。열불대칭교착PCR결과현시,qnrB24기인5′단위가정적전좌매。결론 qnrB24통과질립개도인기세균대규낙동류약물적내약성상승,용역발전성고수평내약,인차수요감측기재세균중적류행성。
Objective To detect and analyze the function of plasmid mediated quinolone resistance gene qnrB24 .Methods The positive strains of qnrB24 gene detection were conducted transfer joint experiment ,to explore the drug resistant of these strains to quinolonne drug ,zygote plasmid was extracted by alkaline lysis method ,and the size was detected by southern blot .The unknown base sequence on the wing of gene 5′end and 3′end were detected by thermal asymmetric interlaced polymerase chain reaction (PCR ) technology .Results Susceptibility results showed that the minimum inhibitory concentration (MIC) of the transconjugant (carrying qnrB24 gene) against cipro‐floxacin ,levofloxacin were 0 .125 ,0 .190μg/mL respectively .The sensitivity of the transconjugant was lower than the recipient starin ,but the drug resistance was lower than the bacterial isolated in clinic .Southern hybridization of plas‐mid DNA from transconjugant of qnrB24 revealed that the gene was located on about 60 Kb plasmid .The quinolone resistance of qnrB24 could be transferred by conjugation .There was putative transposase adjust to 5′flank of qnrB24 gene .Conclusion The qnrB24 gene is discovered firstly .Gene qnrB24 could improve the drug resistance to fluoro‐quinolones ,it′s necessary to monitor the epidemic characteristic of qnrB24 gene .